CADL is currently covered by 5 analysts with an average price target of $16. This is a potential upside of $7.61 (90.7%) from yesterday's end of day stock price of $8.39.
Candel Therapeutics's activity chart (see below) currently has 17 price targets and 29 ratings on display. The stock rating distribution of CADL is 75% BUY and 25% HOLD.
Analysts' price targets on this stock were met 16.67% of the time, taking 46.67 days on average.
Highest price target for CADL is $23, Lowest price target is $13, average price target is $16.
Most recent stock forecast was given by JOHN NEWMAN from CANACCORD. First documented stock forecast 23-Aug-2021.
Currently out of the existing stock ratings of CADL, 9 are a BUY (75%), 3 are a HOLD (25%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Feb-2025
$13
$4.61 (54.95%)
Hold Since 17-May-2026
$18
$9.61 (114.54%)
$12
1 months 25 days ago
(20-Sep-2026)
3/5 (60%)
$6.79 (60.57%)
83
Buy Since 28-Sep-2025
$23
$14.61 (174.14%)
$23
3 months 2 days ago
(12-Aug-2026)
0/5 (0%)
$11.2 (94.92%)
Buy Since 20-Feb-2025
$22
7 months 28 days ago
(18-Mar-2026)
0/2 (0%)
$17.33 (371.09%)
Buy Since 28-Oct-2025
$15
$5.21 (53.22%)
$15
11 months 7 days ago
(08-Dec-2025)
0/2 (0%)
$9.55 (175.23%)
What is CADL (Candel Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on CADL (Candel Therapeutics)?
Which analyst has the most public recommendations on CADL (Candel Therapeutics)?
Which analyst is the currently most bullish on CADL (Candel Therapeutics)?
Which analyst is the currently most reserved on CADL (Candel Therapeutics)?